Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
GOSS
$10.48
-2.78%
GOSS
· Gossamer Bio, Inc.
$10.48
-0.30 (-2.78%)
At close · Oct 7
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company's existing cash and cash equivalents are not sufficient to fund operating plans for at least one year from the issuance date of these financial statements. Accordingly, these conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$62.21M
Shares
6.11M
Volume · Oct 7
280.69K
Avg daily vol (18 sessions)
340.01K
All webcasts
Earnings call · FY2021 Q1
Gossamer Bio, Inc. (GOSS) Q1 2021 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$62.40
Net income
-$57.64M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed May 6, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed May 6, 2021 · complete as-filed document